Skip to content

Beyond Air, Inc.

XAIR · XNAS

CIK 1641631fmd_1908C632J9KVSWGJ46KS4EWWW3Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Apr 02, 2015 to Sep 30, 2026, 43 periods

Income Statement · Annual · Millions · USD
Line itemFY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Total revenues––811––148
Total interest income––––––––10
Net interest income7–––––––(2)(3)
Cost of revenue––––––1257
Gross profit––––––(1)(1)(2)0
Research and development(4)–411131217241710
Selling, general and administrative–––––––372619
Total operating expenses–––––4152624329
Operating income11–(3)(18)(22)(41)(52)(63)(45)(29)
Interest expense––00110334
Interest and investment income–––––––21–
Other non-operating income (expense)–(1)(3)(2)(1)(3)(7)(1)(4)(5)
Income before taxes18–(7)(20)(23)(44)(59)(64)(48)(34)
Income tax expense–––(0)––––––
Net income from continuing operations–––(20)––––––
Net income(18)–(7)(20)(23)(43)(56)(60)(47)(33)
Net income to common shareholders(18)–(7)(20)(23)–––––
Beyond Air, Inc. (XAIR) financial statements · FinancialMD